Featured Articles

  1. Cost Modeling Analysis Of AAV And LV Manufacturing 3/31/2026

    Manufacturing scale plays a critical role in viral vector economics. Compare AAV and LV production scenarios to gain insight into how intermediate-scale strategies can reduce cost and risk.

  2. Why Choose A Modular Automated Approach To CAR T Manufacturing? 2/24/2026

    Get a clear, data-driven look at the biggest pressure points in cell therapy manufacturing. Explore the trends shaping today’s production challenges and where new opportunities are emerging.

  3. The New Economics Of Cell Therapy Manufacturing 2/24/2026

    Cell therapy’s future hinges not just on scientific progress but on scalable manufacturing. Explore why reliability and productivity now shape viability and how modernizing operations can support growth.

  4. Understanding Adeno-Associated Virus Vector Impurities 11/13/2025

    AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.

  5. Cell Culture Media Demystified For Performance, Quality, And Innovation 11/13/2025

    Cell culture media isn’t one-size-fits-all. Learn how media composition, customization, and analytics can dramatically improve cell growth, productivity, and product quality for complex processes.

  6. Scale-Up Of A Transient rAAV Production Process 11/3/2025

    Scalable rAAV production is achievable with a transient cell line and optimized bioreactor setup, delivering high titers and reduced impurities, now validated at 200 L scale for commercial readiness.

  7. Scale-Up Of An Adherent rAAV Production Process 11/3/2025

    Fixed-bed bioreactors simplify the scale-up of viral vector production. Discover a system that bridges development and manufacturing with data confirming consistent performance across scales.

  8. A Simple Method For Cell Growth Media Preparation 11/3/2025

    Explore how powder media and sterile fluid handling can reduce contamination risk and improve efficiency in viral vector production, especially for HEK293-based AAV workflows.

  9. Exosome Production From hMSC Using A Fixed-Bed Bioreactor 11/3/2025

    Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.

  10. Research-Scale Oligonucleotide Workflow 10/30/2025

    Get a clear view of oligonucleotide development from synthesis to purification and filtration with practical insights to help you streamline workflows and stay ahead in the fight against disease.